The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Smulevich A.B.

Sechenov First Moscow State Medical University of Ministry of health of the Russia, Moscow, Russia

Briko N.I.

Sechenov First Moscow State Medical University, Moscow, Russia

Andryushchenko A.V.

Moscow Scientific and Practical Center of Dermatovenereology and Cosmetology, Moscow, Russia, 119071

Romanov D.V.

FGBU "Nauchnyĭ tsentr psikhicheskogo zdorov'ia" RAMN, Moskva;
NOKTs "Psikhosomaticheskaia meditsina" Pervogo Moskovskogo gosudarstvennogo meditsinskogo universiteta im. I.M. Sechenova, Moskva

Shuliak Iu.A.

Kafedra psikhologicheskogo konsul'tirovaniia, psikhokorrektsii i psikhoterapii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Brazhnikov А.Yu.

Sechenov First Moscow State Medical University, Moscow

Gerasimov A.N.

Sechenov First Moscow State Medical University, Moscow, Russia

Melik-pashaian A.E.

Heratsi Yerevan State Medical University, Yerevan, Armenia

Mironova E.V.

Heratsi Yerevan State Medical University, Yerevan, Armenia

Pushkarev D.F.

Sechenov First Moscow State Medical University, Moscow

Comorbidity of depression and nonaffective — schizophrenia spectrum disorders: the clinical-epidemiological study EDIP

Authors:

Smulevich A.B., Briko N.I., Andryushchenko A.V., Romanov D.V., Shuliak Iu.A., Brazhnikov А.Yu., Gerasimov A.N., Melik-pashaian A.E., Mironova E.V., Pushkarev D.F.

More about the authors

Views: 6329

Downloaded: 132


To cite this article:

Smulevich AB, Briko NI, Andryushchenko AV, et al. . Comorbidity of depression and nonaffective — schizophrenia spectrum disorders: the clinical-epidemiological study EDIP. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(11‑2):6‑19. (In Russ.)
https://doi.org/10.17116/jnevro20151151126-19

Recommended articles:
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Features of cognitive impairment in bipo­lar affe­ctive diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):15-19
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132
Schi­zophrenia spectrum diso­rders (aspects of psychopathology and clinical taxo­nomy). S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):7-16
Controversial issues of diagnosis and theoretical concepts of schi­zophrenia in childhood. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):17-24
Psychological concepts — design of clinical models of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):25-31

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.